Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Constance Mukabatsinda"'
Autor:
Philip Grant, Fabienne Shumbusho, Jennifer Ilo Van Nuil, Fredrick Kateera, Joia Mukherjee, Jules Kabahizi, Fabien Ntaganda, Sabin Nsanzimana, Aimable Mbituyumuremyi, Makuza Jean Damascene, Claude Mambo Muvunyi, Constance Mukabatsinda, Emmanuel Musabeyezu, Cyprien Ntirenganya, Neil Gupta
Publikováno v:
Hepatology Communications, Vol 4, Iss 4, Pp 569-576 (2020)
Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy,
Externí odkaz:
https://doaj.org/article/f713c5424c644477a299283a32ddc6cd
Autor:
Stephanie Popping, Debora Bade, Charles Boucher, Mark van der Valk, Manal El-Sayed, Olafsson Sigurour, Vana Sypsa, Timothy Morgan, Amiran Gamkrelidze, Constance Mukabatsinda, Sylvie Deuffic-Burban, Michael Ninburg, Jordan Feld, Margaret Hellard, John Ward
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss 1, Pp 60-66 (2019)
Hepatitis B virus (HBV) and hepatitis C virus (HCV) affect more than 320 million people worldwide, which is more than HIV, tuberculosis (TB) and malaria combined. Elimination of HBV and HCV will, therefore, produce substantial public health and econo
Externí odkaz:
https://doaj.org/article/cd9edc1cbd154a6ab645abc64333f50f
Autor:
Neil Gupta, Jules Kabahizi, Constance Mukabatsinda, Timothy David Walker, Emmanuel Musabeyezu, Athanase Kiromera, Jennifer Ilo Van Nuil, Kevin Steiner, Joia Mukherjee, Sabin Nsanzimana, Aimable Mbituyumuremyi
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174148 (2017)
BACKGROUND:Access to treatment for hepatitis C virus (HCV) in sub-Saharan Africa is extremely limited. With the advent of direct acting antivirals (DAAs), highly effective and easy-to-deliver oral regimens are now available on the global market. This
Externí odkaz:
https://doaj.org/article/1df48508454142b0a4add4793c486eec
Autor:
Neil Gupta, Jules Kabahizi, Emmanuel Musabeyezu, Alain Mukuralinda, Claude Mambo Muvunyi, Sabin Nsanzimana, Fabienne Shumbusho, Constance Mukabatsinda, Aimable Mbituyumuremi, Jennifer Ilo Van Nuil, Fredrick Kateera, Joia Mukerjee
Publikováno v:
BASE-Bielefeld Academic Search Engine
An estimated 71 million people live with hepatitis C virus (HCV) and without an effective vaccination, control efforts depend entirely on prevention, early diagnosis, and treatment with direct acting antiviral medication. The experiences of accessing
Autor:
Fabienne Shumbusho, Sabin Nsanzimana, Joia S. Mukherjee, Fredrick Kateera, Aimable Mbituyumuremyi, Claude Mambo Muvunyi, Emmanuel Musabeyezu, Constance Mukabatsinda, Neil Gupta, Cyprien Ntirenganya, Philip M. Grant, Jules Kabahizi, Makuza Jean Damascene, Fabien Ntaganda, Jennifer Ilo Van Nuil
Publikováno v:
Hepatology Communications
BASE-Bielefeld Academic Search Engine
Hepatology Communications, Vol 4, Iss 4, Pp 569-576 (2020)
BASE-Bielefeld Academic Search Engine
Hepatology Communications, Vol 4, Iss 4, Pp 569-576 (2020)
Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy,
Autor:
Neil Gupta, Linda Manirambona, Fabienne Shumbusho, Jules Kabihizi, Anthere Murangwa, Janvier Serumondo, Jean Damascene Makuza, Sabin Nsanzimana, Claude Mambo Muvunyi, Constance Mukabatsinda, Emmanuel Musabeyezu, Gregory Camus, Philip M Grant, Fredrick Kateera
Publikováno v:
The lancet. Gastroenterologyhepatology. 7(6)
Hepatitis C virus (HCV) genotype 4 non-a/d subtypes, which frequently have NS5A resistance-associated substitutions, are highly prevalent in sub-Saharan Africa. These subtypes, particularly genotype 4r, have been associated with higher rates of failu
Autor:
Olafsson Sigurour, Jordan J. Feld, Margaret Hellard, Timothy R. Morgan, Sylvie Deuffic-Burban, Constance Mukabatsinda, Michael Ninburg, Amiran Gamkrelidze, Vana Sypsa, Stephanie Popping, Mark van der Valk, John W. Ward, Manal Elsayed, Debora Bade, Charles A. Boucher
Publikováno v:
Journal of Virus Eradication
Journal of virus eradication, vol 5, iss 1
Journal of Virus Eradication, 5(1), 60-66. Elsevier Ltd.
Journal of Virus Eradication, Vol 5, Iss 1, Pp 60-66 (2019)
Journal of virus eradication, vol 5, iss 1
Journal of Virus Eradication, 5(1), 60-66. Elsevier Ltd.
Journal of Virus Eradication, Vol 5, Iss 1, Pp 60-66 (2019)
Hepatitis B virus (HBV) and hepatitis C virus (HCV) affect more than 320 million people worldwide, which is more than HIV, tuberculosis (TB) and malaria combined. Elimination of HBV and HCV will, therefore, produce substantial public health and econo
Autor:
Sabin Nsanzimana, Jules Kabahizi, Joia S. Mukherjee, Makuza Jean Damascene, Fredrick Kateera, Aimable Mbituyumuremyi, Neil Gupta, Fabien Ntaganda, Jennifer Ilo Van Nuil, Cyprien Ntirenganya, Claude Mambo Muvunyi, Emmanuel Musabeyezu, Philip M. Grant, Constance Mukabatsinda, Fabienne Shumbusho, Gregory Camus
Publikováno v:
Lancet Gastroenterology and Hepatology. 4(2)
BACKGROUND: Limited treatment data are available for hepatitis C virus (HCV) in sub-Saharan Africa, especially for genotype 4. Our objective was to establish the safety and efficacy of ledipasvir-sofosbuvir for chronic HCV genotype 1 or 4 infection i
Autor:
Tim Walker, Patrick Kyamanywa, Sanctus Musafiri, Georges Ntakiyiruta, Emmanuel Kayibanda, Ainhoa Costas-Chavarri, Zeta Mutabazi, Faith C. Robertson, Constance Mukabatsinda, John W. Scott
Publikováno v:
World journal of surgery. 43(2)
Laparoscopy has proven to be feasible and effective at reducing surgical morbidity and mortality in low resource settings. In Rwanda, the demand for and perceived challenges to laparoscopy use remain unclear. A mixed-methods study was performed at th
Autor:
Tim Walker, Jules Kabahizi, Neil Gupta, Sabin Nsanzimana, Constance Mukabatsinda, Athanase Kiromera, Jennifer Ilo Van Nuil, Emmanuel Musabeyezu, Joia S. Mukherjee, Kevin Steiner, Aimable Mbituyumuremyi
Publikováno v:
BASE-Bielefeld Academic Search Engine
PLoS ONE, Vol 12, Iss 3, p e0174148 (2017)
PLoS ONE
PLoS ONE, Vol 12, Iss 3, p e0174148 (2017)
PLoS ONE
Background Access to treatment for hepatitis C virus (HCV) in sub-Saharan Africa is extremely limited. With the advent of direct acting antivirals (DAAs), highly effective and easy-to-deliver oral regimens are now available on the global market. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5626c04d69d144aedc826c0126312e2a
https://ora.ox.ac.uk/objects/uuid:77828410-0c9e-44e8-bec9-d72543340981
https://ora.ox.ac.uk/objects/uuid:77828410-0c9e-44e8-bec9-d72543340981